VOR Vor Biopharma Inc.
Healthcare$14.04+0.00%OpenMarket Cap: $96.3M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.04
P/S
0.00
EV/EBITDA
0.06
DCF Value
$39.40
FCF Yield
-153.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
87.3%
ROA
-174.3%
ROIC
-76.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-35.2M | $-219.6M | $— | — |
| Q4 null | $0.00 | NaN% | $-36.0M | $1.72B | $— | — |
| FY null | $0.00 | NaN% | $-371.6M | $-696.0M | $— | — |
| Q3 null | $0.00 | NaN% | $-28.1M | $-812.7M | $— | — |
| Q2 null | $0.00 | NaN% | $-274.3M | $-1.57B | $— | — |
| Q1 null | $0.00 | NaN% | $-33.3M | $-32.5M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-31.3M | $-30.7M | $— | — |
| FY null | $0.00 | NaN% | $-121.2M | $-116.9M | $— | — |
| Q3 null | $0.00 | NaN% | $-28.5M | $-27.6M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-29.0M | $-27.8M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-32.3M | $-30.8M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-28.1M | $-26.3M | $-7.80 | — |